Sat, Dec 27, 2014, 1:56 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Aradigm Corporation Message Board

  • rehdvm2004 rehdvm2004 May 29, 2013 6:25 PM Flag

    Good Read by muck_and_myer was . . .

    a key to what is going to happen in the near to intermediate term future. Besides their cash on hand, ARDM has entered into a funding on milestones/marketing deal for a "sure win" inhalational antibiotic. Lots of reasons that I have mentioned before. BTW, I wrote the antibiotic treatment protocol for the TBRC at MGH for big animals that got lung, heart, kidney and liver transplants. Also a few beta islet transplants. The key antibiotic was a fluoroquinolone like Cipro, but it was the one for mammals. Not humans. This stock has finally found a mentor company. Do the DD on Grifols and draw your own conclusions. The drug still has to get into and through Phase III clinical trial, but that is almost a certainty will get a protocol in front of the FDA and EMEA in 4 months and will go from there. If they hook up with the Chiltren International Group that seems to be able to get 70 or more clinical sites online in 45 days, the study should be completed quickly depending on days treated and days rest. That has been 28 days of treatment and 28 days of rest for CF/Pa protocols. I just hope they do not waste time comparing with inhalational TOBI solution, which is being replaced by inhalational tobramycin powder or TIP by Novartis. We shall see.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ARDM
7.9474-0.0225(-0.28%)Dec 26 10:57 AMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.